BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33430189)

  • 1. Recruitment and Baseline Characteristics of Participants in the AgeWell.de Study-A Pragmatic Cluster-Randomized Controlled Lifestyle Trial against Cognitive Decline.
    Röhr S; Zülke A; Luppa M; Brettschneider C; Weißenborn M; Kühne F; Zöllinger I; Samos FZ; Bauer A; Döhring J; Krebs-Hein K; Oey A; Czock D; Frese T; Gensichen J; Haefeli WE; Hoffmann W; Kaduszkiewicz H; König HH; Thyrian JR; Wiese B; Riedel-Heller SG
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33430189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients.
    Zülke A; Luck T; Pabst A; Hoffmann W; Thyrian JR; Gensichen J; Kaduszkiewicz H; König HH; Haefeli WE; Czock D; Wiese B; Frese T; Röhr S; Riedel-Heller SG
    BMC Geriatr; 2019 Aug; 19(1):203. PubMed ID: 31370792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to a lifestyle intervention - just a question of self-efficacy? Analysis of the AgeWell.de-intervention against cognitive decline.
    Wittmann FG; Pabst A; Zülke A; Luppa M; Oey A; Boekholt M; Weise S; Fankhänel T; Kosilek RP; Brettschneider C; Döhring J; Lunden L; Wiese B; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Thyrian JR; Riedel-Heller SG
    Alzheimers Res Ther; 2024 Jun; 16(1):133. PubMed ID: 38909256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multidomain intervention against cognitive decline in an at-risk-population in Germany: Results from the cluster-randomized AgeWell.de trial.
    Zülke AE; Pabst A; Luppa M; Roehr S; Seidling H; Oey A; Cardona MI; Blotenberg I; Bauer A; Weise S; Zöllinger I; Sanftenberg L; Brettschneider C; Döhring J; Lunden L; Czock D; Haefeli WE; Wiese B; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Thyrian JR; Riedel-Heller SG
    Alzheimers Dement; 2024 Jan; 20(1):615-628. PubMed ID: 37768074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who Benefited the Most? Effectiveness of a Lifestyle Intervention Against Cognitive Decline in Older Women and Men - Secondary Analysis of the AgeWell.de-trial.
    Wittmann FG; Pabst A; Zülke A; Luppa M; Blotenberg I; Cardona MI; Bauer A; Fuchs S; Zöllinger I; Sanftenberg L; Brettschneider C; Döhring J; Lunden L; Czock D; Wiese B; Thyrian JR; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Riedel-Heller SG
    J Prev Alzheimers Dis; 2024; 11(2):348-355. PubMed ID: 38374741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults-study design and baseline characteristics of the FINGER-NL randomized controlled trial.
    Deckers K; Zwan MD; Soons LM; Waterink L; Beers S; van Houdt S; Stiensma B; Kwant JZ; Wimmers SCPM; Heutz RAM; Claassen JAHR; Oosterman JM; de Heus RAA; van de Rest O; Vermeiren Y; Voshaar RCO; Smidt N; Broersen LM; Sikkes SAM; Aarts E; ; ; Köhler S; van der Flier WM
    Alzheimers Res Ther; 2024 Jun; 16(1):126. PubMed ID: 38872204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere Length Change in a Multidomain Lifestyle Intervention to Prevent Cognitive Decline: A Randomized Clinical Trial.
    Sindi S; Solomon A; Kåreholt I; Hovatta I; Antikainen R; Hänninen T; Levälahti E; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Peltonen M; Singh Khalsa D; Wolozin B; Strandberg T; Tuomilehto J; Soininen H; Ngandu T; Kivipelto M;
    J Gerontol A Biol Sci Med Sci; 2021 Feb; 76(3):491-498. PubMed ID: 33175128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Eligibility Criteria on Patient Selection and Treatment Implications from 10 Multidomain Dementia Prevention Trials: A Population-Based Study.
    Licher S; Wolters FJ; Pavlović J; Kavousi M; Leening MJG; Ikram MK; Ikram MA
    Neuroepidemiology; 2023; 57(1):14-24. PubMed ID: 36398446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifiable dementia risk score to study heterogeneity in treatment effect of a dementia prevention trial: a post hoc analysis in the preDIVA trial using the LIBRA index.
    van Middelaar T; Hoevenaar-Blom MP; van Gool WA; Moll van Charante EP; van Dalen JW; Deckers K; Köhler S; Richard E
    Alzheimers Res Ther; 2018 Jun; 10(1):62. PubMed ID: 29960597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.
    Ngandu T; Lehtisalo J; Solomon A; Levälahti E; Ahtiluoto S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lindström J; Mangialasche F; Paajanen T; Pajala S; Peltonen M; Rauramaa R; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
    Lancet; 2015 Jun; 385(9984):2255-63. PubMed ID: 25771249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress.
    Kivipelto M; Solomon A; Ahtiluoto S; Ngandu T; Lehtisalo J; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lindström J; Mangialasche F; Nissinen A; Paajanen T; Pajala S; Peltonen M; Rauramaa R; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H
    Alzheimers Dement; 2013 Nov; 9(6):657-65. PubMed ID: 23332672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial.
    Rosenberg A; Ngandu T; Rusanen M; Antikainen R; Bäckman L; Havulinna S; Hänninen T; Laatikainen T; Lehtisalo J; Levälahti E; Lindström J; Paajanen T; Peltonen M; Soininen H; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Solomon A; Kivipelto M
    Alzheimers Dement; 2018 Mar; 14(3):263-270. PubMed ID: 29055814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment.
    Richard E; Jongstra S; Soininen H; Brayne C; Moll van Charante EP; Meiller Y; van der Groep B; Beishuizen CR; Mangialasche F; Barbera M; Ngandu T; Coley N; Guillemont J; Savy S; Dijkgraaf MG; Peters RJ; van Gool WA; Kivipelto M; Andrieu S
    BMJ Open; 2016 Jun; 6(6):e010806. PubMed ID: 27288376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing Behavioral Lifestyle Risk Factors Related to Cognitive Decline in Later Life Using a Self-Motivated eHealth Intervention in Dutch Adults.
    Aalbers T; Qin L; Baars MA; de Lange A; Kessels RP; Olde Rikkert MG
    J Med Internet Res; 2016 Jun; 18(6):e171. PubMed ID: 27317506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Online, Person-Centered, Risk Factor Management Program to Prevent Cognitive Decline: Protocol for A Prospective Behavior-Modification Blinded Endpoint Randomized Controlled Trial.
    Lim YY; Ayton D; Perin S; Lavale A; Yassi N; Buckley R; Barton C; Bruns L; Morello R; Pirotta S; Rosenich E; Rajaratnam SMW; Sinnott R; Brodtmann A; Bush AI; Maruff P; Churilov L; Barker A; Pase MP;
    J Alzheimers Dis; 2021; 83(4):1603-1622. PubMed ID: 34420970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming Pandemic-Related Challenges in Recruitment and Screening: Strategies and Representation of Older Women With Cardiovascular Disease for a Multidomain Lifestyle Trial to Prevent Cognitive Decline.
    Halloway S; Volgman AS; Schoeny ME; Arvanitakis Z; Barnes LL; Pressler SJ; Vispute S; Braun LT; Tafini S; Williams M; Wilbur J
    J Cardiovasc Nurs; 2024 Jul-Aug 01; 39(4):359-370. PubMed ID: 37167428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.
    Heffernan M; Andrews G; Fiatarone Singh MA; Valenzuela M; Anstey KJ; Maeder AJ; McNeil J; Jorm L; Lautenschlager NT; Sachdev PS; Ginige JA; Hobbs MJ; Boulamatsis C; Chau T; Cobiac L; Cox KL; Daniel K; Flood VM; Guerrero Y; Gunn J; Jain N; Kochan NA; Lampit A; Mavros Y; Meiklejohn J; Noble Y; O'Leary F; Radd-Vagenas S; Walton CC; ; Brodaty H
    J Alzheimers Dis; 2019; 70(s1):S221-S237. PubMed ID: 30475762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Remote Intervention to Prevent or Delay Cognitive Impairment in Older Adults: Design, Recruitment, and Baseline Characteristics of the Virtual Cognitive Health (VC Health) Study.
    Bott N; Kumar S; Krebs C; Glenn JM; Madero EN; Juusola JL
    JMIR Res Protoc; 2018 Aug; 7(8):e11368. PubMed ID: 30104186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intellectual and physical activities, but not social activities, are associated with better global cognition: a multi-site evaluation of the cognition and lifestyle activity study for seniors in Asia (CLASSA).
    Lam LC; Ong PA; Dikot Y; Sofiatin Y; Wang H; Zhao M; Li W; Dominguez J; Natividad B; Yusoff S; Fu JL; Senanarong V; Fung AW; Lai K
    Age Ageing; 2015 Sep; 44(5):835-40. PubMed ID: 26271049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Multidomain Lifestyle Intervention on Estimated Dementia Risk.
    Solomon A; Handels R; Wimo A; Antikainen R; Laatikainen T; Levälahti E; Peltonen M; Soininen H; Strandberg T; Tuomilehto J; Kivipelto M; Ngandu T
    J Alzheimers Dis; 2021; 82(4):1461-1466. PubMed ID: 34151805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.